Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05552976 |
|---|---|
| Brief Title: | A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) (SUCCESSOR-2) |
| First Submitted : | September 21, 2022 |
| First Submitted that Met QC Criteria : | September 21, 2022 |
| First Posted : | September 23, 2022 |
| Last Update Submitted that Met QC Criteria : | May 1, 2024 |
| Last Update Posted : | May 2, 2024 |